Certara stock

Shares of Certara, Inc. (NASDAQ:CERT – Get Free Report) have earned an average recommendation of “Hold” from the eight research firms that are currently covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1 ….

ETF Watch. Macquarie Introduces Its First U.S. ETFs. Gabe Alpert | Nov 30, 2023. Our CERT ETF report shows the ETFs with the most CERT exposure, the top performing CERT ETFs, and most popular CERT ... Patrick Smith CERT stock SEC Form 4 insiders trading. Patrick has made over 6 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Patrick sold 19,104 units of CERT stock worth $411,691 on 5 June 2023.19,104 units of CERT stock worth $411,691 on 5 June 2023.

Did you know?

PRINCETON, N.J.—September 3, 2021. Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a proposed underwritten public offering of 20,000,000 shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission. Certara is offering 4,500,000 shares of common stock and ...Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Certara Inc have a median target of 19.00, with a high estimate of 21.00 and a low estimate of 16.00. The median estimate ... Arsenal will acquire approximately 30M shares at $15 per share from funds controlled by EQT Private Equity and agrees to two-year lock-up on sale of shares. PRINCETON, N.J.— November 7, 2022 — Certara, Inc. (Nasdaq: CERT) today announced that Arsenal Capital Partners (“Arsenal”), a private equity firm specializing in investing in and building transformational healthcare companies, has ...

Mar 14, 2023 · Certara, Inc. (CERT) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year ... Certara stock ( CERT) appears to check all the boxes. Nominated by one of our lovely subscribers, the New Jerzee-based company serves the drug development industry by offering software and services around its biosimulation platform. It claims to compete indirectly with companies like Schrödinger ( SDGR ), which uses a …ClearBridge Investments highlighted stocks like Certara, Inc. (NASDAQ: CERT) in its Q3 2022 investor letter. Headquartered in Princeton, New Jersey, Certara, Inc. (NASDAQ:CERT) is a software ...Certara, Inc. (“Certara”) (NASDAQ:CERT) recently completed an underwritten public offering of 10000000 shares of its common stock by certain existing ...

The estimated Net Worth of Leif E Pedersen is at least $5.68 Million dollars as of 22 November 2022. Mr Pedersen owns over 51,223 units of Certara stock worth over $2,820,285 and over the last 2 years he sold CERT stock worth over $2,563,711. In addition, he makes $295,397 as Pres of Software at Certara.Certara Inc stock performance at a glance. Check Certara Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. ….

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Certara stock. Possible cause: Not clear certara stock.

See the latest Certara Inc Ordinary Shares stock price (CERT:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Josh Xie is Director-Clinical Pharmacology at Certara, Inc. ... Stock quotes are provided by Factset, Morningstar and S&P Capital IQ Stock markets for all 100% Free Registration. 100% Free Registration

Inclisiran is a novel N-acetylgalactosamine (GalNAc) conjugated small-interfering ribonucleic acid (siRNA) therapy designed to specifically target proprotein convertase subtilisin/kexin type 9 (PCSK9) mRNA in the liver for the treatment of hypercholesterolemia.How much is Certara stock worth today? ( NASDAQ: CERT) Certara currently has 159,844,780 outstanding shares. With Certara stock trading at $14.64 per share, the total value of Certara stock (market capitalization) is $2.34B. Certara stock was originally listed at a price of $33.59 in Dec 14, 2020.

online bank accounts with virtual cards About Certara Certara accelerates medicines using biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,300 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Learn more at Certara.com. Certara Contact: broker dealer vs investment advisorduke energy Inclisiran is a novel N-acetylgalactosamine (GalNAc) conjugated small-interfering ribonucleic acid (siRNA) therapy designed to specifically target proprotein convertase subtilisin/kexin type 9 (PCSK9) mRNA in the liver for the treatment of hypercholesterolemia.78.45. +1.10%. 26.59M. View today's Certara Inc stock price and latest CERT news and analysis. Create real-time notifications to follow any changes in the live stock price. best intro to coding course 8 brokerages have issued 1 year price objectives for Certara's stock. Their CERT share price targets range from $16.00 to $24.00. On average, they expect the company's share price to reach $19.71 in the next twelve months. This suggests a possible upside of 31.7% from the stock's current price. mbs bondsvxus dividend yieldhow to buy lucid stock See the latest Certara Inc Ordinary Shares stock price (CERT:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Discover historical prices for CERT stock on Yahoo Finance. View daily, weekly or monthly format back to when Certara, Inc. stock was issued. ... Certara, Inc. (CERT) NasdaqGS - NasdaqGS Real Time ... silver futures forecast Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Here are 5 tips to streamline developing a detailed SOC that will help relieve some of the last-minute stress: 1. During the kickoff meeting, ask your regulatory affairs representative whether a detailed SOC is required. Frequently, a high-level overview of changes and the rationale for these changes is sufficient. barrinsconsumer staples stockssuperconductor stocks Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...